Advertisement

Physician's First Watch

Physician's First Watch

Medical news from NEJM Journal Watch

May 29, 2015

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

The FBI is investigating uterine power morcellators, including whether their largest manufacturer — Johnson

Comments (0)

By Kelly Young

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Unintentional injection of soft tissue fillers into blood vessels on the face can lead to embolization, the FDA cautioned on Thursday. The...

Comments (0)

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Knowledge+ Blog: Nate Kornell, a research psychologist at Williams College,...

Comments (0)

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Hispanic Americans — particularly those aged 45 and up — commonly have impaired hearing, according to a JAMA Otolaryngology—Head

Comments (0)

By Kristin J. Kelley

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Eluxadoline (Viberzi) and rifaximin (Xifaxan) have both been approved to treat irritable bowel syndrome with diarrhea.

The approvals...

Comments (1)

May 28, 2015

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Perioperative beta-blockade in patients undergoing noncardiac surgery is associated with reduced mortality only in those with three or more risk factors,...

Comments (0)

By the Editors

Early treatment for patients with HIV is associated with over a 50% reduction in risk for serious illness or death, according to study data released by the National Institute of Allergy and...

Comments (0)

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Most of the 100-plus genes commonly included in gene panel tests have no known link to breast cancer, researchers argue in the New England Journal of Medicine.

They note that such...

Comments (0)

By Kristin J. Kelley

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

The FDA has approved a once-daily inhalation spray (marketed as Stiolto Respimat) for...

Comments (0)

Pages